{"id":"RCV000013444","variation_id":"12610","review_status":"reviewed by expert panel","title":"NM_005343.4(HRAS):c.173C\u003eT (p.Thr58Ile) AND Costello syndrome","interpretation":"Pathogenic","trait_set_id":"3420","date_last_evaluated":"2017-04-03","version":"20","variation_archive_id":"VCV000012610","submission_count":"4"}
{"id":"RCV000458634","variation_id":"37594","review_status":"criteria provided, single submitter","title":"NM_007294.3(BRCA1):c.446A\u003eC (p.Glu149Ala) AND Hereditary breast and ovarian cancer syndrome","interpretation":"Uncertain significance","trait_set_id":"7920","date_last_evaluated":"2018-12-19","version":"4","variation_archive_id":"VCV000037594","submission_count":"1"}
{"id":"RCV000039762","variation_id":"46503","review_status":"criteria provided, multiple submitters, no conflicts","title":"NM_033056.4(PCDH15):c.5565C\u003eT (p.Ala1855=) AND not specified","interpretation":"Likely benign","trait_set_id":"9590","date_last_evaluated":"2017-11-21","version":"5","variation_archive_id":"VCV000046503","submission_count":"2"}
{"id":"RCV000381540","variation_id":"46503","review_status":"criteria provided, single submitter","title":"NM_033056.4(PCDH15):c.5565C\u003eT (p.Ala1855=) AND Retinitis pigmentosa-deafness syndrome","interpretation":"Uncertain significance","trait_set_id":"2631","date_last_evaluated":"2016-06-14","version":"1","variation_archive_id":"VCV000046503","submission_count":"1"}
{"id":"RCV000727222","variation_id":"46503","review_status":"criteria provided, single submitter","title":"NM_033056.4(PCDH15):c.5565C\u003eT (p.Ala1855=) AND not provided","interpretation":"Uncertain significance","trait_set_id":"9460","date_last_evaluated":"2018-05-30","version":"1","variation_archive_id":"VCV000046503","submission_count":"1"}
{"id":"RCV000326661","variation_id":"46503","review_status":"criteria provided, single submitter","title":"NM_033056.4(PCDH15):c.5565C\u003eT (p.Ala1855=) AND Nonsyndromic Hearing Loss, Recessive","interpretation":"Uncertain significance","trait_set_id":"33370","date_last_evaluated":"2016-06-14","version":"1","variation_archive_id":"VCV000046503","submission_count":"1"}
{"id":"RCV000726979","variation_id":"48176","review_status":"criteria provided, single submitter","title":"NM_194248.3(OTOF):c.1630C\u003eT (p.Arg544Cys) AND not provided","interpretation":"Uncertain significance","trait_set_id":"9460","date_last_evaluated":"2016-12-20","version":"1","variation_archive_id":"VCV000048176","submission_count":"1"}
{"id":"RCV000041467","variation_id":"48176","review_status":"criteria provided, single submitter","title":"NM_194248.3(OTOF):c.1630C\u003eT (p.Arg544Cys) AND not specified","interpretation":"Uncertain significance","trait_set_id":"9590","date_last_evaluated":"2018-08-21","version":"6","variation_archive_id":"VCV000048176","submission_count":"1"}
{"id":"RCV000357820","variation_id":"48176","review_status":"criteria provided, single submitter","title":"NM_194248.3(OTOF):c.1630C\u003eT (p.Arg544Cys) AND Nonsyndromic Hearing Loss, Recessive","interpretation":"Uncertain significance","trait_set_id":"33370","date_last_evaluated":"2016-06-14","version":"1","variation_archive_id":"VCV000048176","submission_count":"1"}
{"id":"RCV000259072","variation_id":"7884","review_status":"criteria provided, single submitter","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND not specified","interpretation":"Benign","trait_set_id":"9590","date_last_evaluated":"2016-11-17","version":"1","variation_archive_id":"VCV000007884","submission_count":"1"}
{"id":"RCV000787769","variation_id":"7884","review_status":"no assertion criteria provided","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Retinitis pigmentosa","interpretation":"Pathogenic","trait_set_id":"6496","date_last_evaluated":"2018-04-01","version":"1","variation_archive_id":"VCV000007884","submission_count":"1"}
{"id":"RCV000393715","variation_id":"7884","review_status":"criteria provided, single submitter","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Retinitis Pigmentosa, Recessive","interpretation":"Likely benign","trait_set_id":"33382","date_last_evaluated":"2016-06-14","version":"1","variation_archive_id":"VCV000007884","submission_count":"1"}
{"id":"RCV000285333","variation_id":"7884","review_status":"criteria provided, single submitter","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Cone-Rod Dystrophy, Recessive","interpretation":"Likely benign","trait_set_id":"33383","date_last_evaluated":"2016-06-14","version":"1","variation_archive_id":"VCV000007884","submission_count":"1"}
{"id":"RCV000393726","variation_id":"7884","review_status":"criteria provided, single submitter","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Macular degeneration","interpretation":"Likely benign","trait_set_id":"33398","date_last_evaluated":"2016-06-14","version":"1","variation_archive_id":"VCV000007884","submission_count":"1"}
{"id":"RCV000340261","variation_id":"7884","review_status":"criteria provided, single submitter","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Stargardt Disease, Recessive","interpretation":"Likely benign","trait_set_id":"33430","date_last_evaluated":"2016-06-14","version":"1","variation_archive_id":"VCV000007884","submission_count":"1"}
{"id":"RCV000008335","variation_id":"7884","review_status":"criteria provided, single submitter","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Stargardt disease 1","interpretation":"Likely pathogenic","trait_set_id":"1448","date_last_evaluated":"2016-01-01","version":"6","variation_archive_id":"VCV000007884","submission_count":"2"}
{"id":"RCV000504806","variation_id":"7884","review_status":"no assertion criteria provided","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Cone/cone-rod dystrophy","interpretation":"Likely pathogenic","trait_set_id":"33742","date_last_evaluated":"2015-01-01","version":"1","variation_archive_id":"VCV000007884","submission_count":"1"}
{"id":"RCV000078671","variation_id":"7884","review_status":"criteria provided, single submitter","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND not provided","interpretation":"Uncertain significance","trait_set_id":"9460","date_last_evaluated":"2018-11-07","version":"7","variation_archive_id":"VCV000007884","submission_count":"2"}
{"id":"RCV000778139","variation_id":"7884","review_status":"criteria provided, single submitter","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND ABCA4-Related Disorders","interpretation":"Uncertain significance","trait_set_id":"33431","date_last_evaluated":"2019-04-05","version":"1","variation_archive_id":"VCV000007884","submission_count":"1"}
{"id":"RCV000015006","variation_id":"13972","review_status":"no assertion criteria provided","title":"NM_004333.6(BRAF):c.1781A\u003eG (p.Asp594Gly) AND Non-Hodgkin lymphoma","interpretation":"Pathogenic","trait_set_id":"3352","date_last_evaluated":"2003-11-17","version":"9","variation_archive_id":"VCV000013972","submission_count":"1"}
{"id":"RCV000037932","variation_id":"13972","review_status":"criteria provided, single submitter","title":"NM_004333.6(BRAF):c.1781A\u003eG (p.Asp594Gly) AND Non-small cell lung cancer","interpretation":"Pathogenic","trait_set_id":"4069","date_last_evaluated":"2012-06-11","version":"2","variation_archive_id":"VCV000013972","submission_count":"1"}
{"id":"RCV000426339","variation_id":"13972","review_status":"no assertion criteria provided","title":"NM_004333.6(BRAF):c.1781A\u003eG (p.Asp594Gly) AND Cutaneous melanoma","interpretation":"Pathogenic","trait_set_id":"12074","date_last_evaluated":"2015-07-14","version":"1","variation_archive_id":"VCV000013972","submission_count":"1"}
{"id":"RCV000443882","variation_id":"13972","review_status":"no assertion criteria provided","title":"NM_004333.6(BRAF):c.1781A\u003eG (p.Asp594Gly) AND Neoplasm of the large intestine","interpretation":"Pathogenic","trait_set_id":"31428","date_last_evaluated":"2016-05-31","version":"1","variation_archive_id":"VCV000013972","submission_count":"1"}
{"id":"RCV000435875","variation_id":"13972","review_status":"no assertion criteria provided","title":"NM_004333.6(BRAF):c.1781A\u003eG (p.Asp594Gly) AND Squamous cell carcinoma of the head and neck","interpretation":"Likely pathogenic","trait_set_id":"1717","date_last_evaluated":"2016-05-31","version":"1","variation_archive_id":"VCV000013972","submission_count":"1"}
{"id":"RCV000426107","variation_id":"13972","review_status":"no assertion criteria provided","title":"NM_004333.6(BRAF):c.1781A\u003eG (p.Asp594Gly) AND Lung adenocarcinoma","interpretation":"Likely pathogenic","trait_set_id":"3349","date_last_evaluated":"2016-05-31","version":"1","variation_archive_id":"VCV000013972","submission_count":"1"}
{"id":"RCV000423919","variation_id":"13972","review_status":"no assertion criteria provided","title":"NM_004333.6(BRAF):c.1781A\u003eG (p.Asp594Gly) AND Malignant melanoma of skin","interpretation":"Likely pathogenic","trait_set_id":"6369","date_last_evaluated":"2016-05-31","version":"1","variation_archive_id":"VCV000013972","submission_count":"1"}
{"id":"RCV000442759","variation_id":"13972","review_status":"no assertion criteria provided","title":"NM_004333.6(BRAF):c.1781A\u003eG (p.Asp594Gly) AND Multiple myeloma","interpretation":"Likely pathogenic","trait_set_id":"6478","date_last_evaluated":"2016-05-31","version":"1","variation_archive_id":"VCV000013972","submission_count":"1"}
{"id":"RCV000418680","variation_id":"13972","review_status":"no assertion criteria provided","title":"NM_004333.6(BRAF):c.1781A\u003eG (p.Asp594Gly) AND Chronic lymphocytic leukemia","interpretation":"Likely pathogenic","trait_set_id":"9305","date_last_evaluated":"2016-05-31","version":"1","variation_archive_id":"VCV000013972","submission_count":"1"}
{"id":"RCV000443065","variation_id":"13972","review_status":"no assertion criteria provided","title":"NM_004333.6(BRAF):c.1781A\u003eG (p.Asp594Gly) AND Neoplasm of brain","interpretation":"Likely pathogenic","trait_set_id":"11864","date_last_evaluated":"2016-05-31","version":"1","variation_archive_id":"VCV000013972","submission_count":"1"}
{"id":"RCV000433779","variation_id":"13972","review_status":"no assertion criteria provided","title":"NM_004333.6(BRAF):c.1781A\u003eG (p.Asp594Gly) AND Adrenocortical carcinoma","interpretation":"Likely pathogenic","trait_set_id":"35132","date_last_evaluated":"2016-05-31","version":"1","variation_archive_id":"VCV000013972","submission_count":"1"}
{"id":"RCV000437006","variation_id":"13972","review_status":"no assertion criteria provided","title":"NM_004333.6(BRAF):c.1781A\u003eG (p.Asp594Gly) AND Transitional cell carcinoma of the bladder","interpretation":"Likely pathogenic","trait_set_id":"35142","date_last_evaluated":"2016-05-31","version":"1","variation_archive_id":"VCV000013972","submission_count":"1"}
{"id":"RCV000000864","variation_id":"822","review_status":"no assertion criteria provided","title":"NM_000038.6(APC):c.3920T\u003eA (p.Ile1307Lys) AND Adenomatous polyposis coli, susceptibility to","interpretation":"risk factor","trait_set_id":"215","date_last_evaluated":"2019-04-01","version":"3","variation_archive_id":"VCV000000822","submission_count":"1"}
{"id":"RCV000000865","variation_id":"822","review_status":"no assertion criteria provided","title":"NM_000038.6(APC):c.3920T\u003eA (p.Ile1307Lys) AND Breast cancer, susceptibility to","interpretation":"risk factor","trait_set_id":"216","date_last_evaluated":"2003-12-01","version":"4","variation_archive_id":"VCV000000822","submission_count":"1"}
{"id":"RCV000210085","variation_id":"822","review_status":"criteria provided, single submitter","title":"NM_000038.6(APC):c.3920T\u003eA (p.Ile1307Lys) AND Colorectal cancer, susceptibility to","interpretation":"risk factor","trait_set_id":"1570","date_last_evaluated":"2015-11-20","version":"1","variation_archive_id":"VCV000000822","submission_count":"1"}
{"id":"RCV000722046","variation_id":"822","review_status":"criteria provided, single submitter","title":"NM_000038.6(APC):c.3920T\u003eA (p.Ile1307Lys) AND Carcinoma of colon","interpretation":"risk factor","trait_set_id":"1735","date_last_evaluated":"2017-01-01","version":"1","variation_archive_id":"VCV000000822","submission_count":"1"}
{"id":"RCV000238802","variation_id":"822","review_status":"criteria provided, single submitter","title":"NM_000038.6(APC):c.3920T\u003eA (p.Ile1307Lys) AND Familial multiple polyposis syndrome","interpretation":"Uncertain significance","trait_set_id":"8942","date_last_evaluated":"2015-11-24","version":"1","variation_archive_id":"VCV000000822","submission_count":"1"}
{"id":"RCV000120049","variation_id":"822","review_status":"criteria provided, multiple submitters, no conflicts","title":"NM_000038.6(APC):c.3920T\u003eA (p.Ile1307Lys) AND not specified","interpretation":"Uncertain significance","trait_set_id":"9590","date_last_evaluated":"2017-02-08","version":"3","variation_archive_id":"VCV000000822","submission_count":"3"}
{"id":"RCV000680453","variation_id":"822","review_status":"criteria provided, single submitter","title":"NM_000038.6(APC):c.3920T\u003eA (p.Ile1307Lys) AND Familial adenomatous polyposis","interpretation":"Uncertain significance","trait_set_id":"35108","date_last_evaluated":"2018-06-01","version":"1","variation_archive_id":"VCV000000822","submission_count":"1"}
{"id":"RCV000115087","variation_id":"822","review_status":"criteria provided, multiple submitters, no conflicts","title":"NM_000038.6(APC):c.3920T\u003eA (p.Ile1307Lys) AND Hereditary cancer-predisposing syndrome","interpretation":"Pathogenic/Likely pathogenic, risk factor","trait_set_id":"13598","date_last_evaluated":"2018-08-01","version":"12","variation_archive_id":"VCV000000822","submission_count":"4"}
{"id":"RCV000020088","variation_id":"822","review_status":"criteria provided, conflicting interpretations","title":"NM_000038.6(APC):c.3920T\u003eA (p.Ile1307Lys) AND Familial adenomatous polyposis 1","interpretation":"Conflicting interpretations of pathogenicity, risk factor","trait_set_id":"6265","date_last_evaluated":"2019-01-14","version":"11","variation_archive_id":"VCV000000822","submission_count":"6"}
{"id":"RCV000034388","variation_id":"822","review_status":"criteria provided, conflicting interpretations","title":"NM_000038.6(APC):c.3920T\u003eA (p.Ile1307Lys) AND not provided","interpretation":"Conflicting interpretations of pathogenicity, risk factor","trait_set_id":"9460","date_last_evaluated":"2018-06-20","version":"6","variation_archive_id":"VCV000000822","submission_count":"6"}
{"id":"RCV000190782","variation_id":"208761","review_status":"criteria provided, single submitter","title":"NM_172107.4(KCNQ2):c.693G\u003eC (p.Glu231Asp) AND Inborn genetic diseases","interpretation":"Likely pathogenic","trait_set_id":"25797","date_last_evaluated":"2015-04-08","version":"2","variation_archive_id":"VCV000208761","submission_count":"1"}
{"id":"RCV000476410","variation_id":"17674","review_status":"criteria provided, single submitter","title":"NM_007294.3(BRCA1):c.4065_4068del (p.Asn1355fs) AND Familial cancer of breast","interpretation":"Pathogenic","trait_set_id":"774","date_last_evaluated":"2017-02-23","version":"1","variation_archive_id":"VCV000017674","submission_count":"1"}
{"id":"RCV000019243","variation_id":"17674","review_status":"reviewed by expert panel","title":"NM_007294.3(BRCA1):c.4065_4068del (p.Asn1355fs) AND Breast-ovarian cancer, familial 1","interpretation":"Pathogenic","trait_set_id":"1917","date_last_evaluated":"2016-04-22","version":"16","variation_archive_id":"VCV000017674","submission_count":"11"}
{"id":"RCV000048431","variation_id":"17674","review_status":"criteria provided, multiple submitters, no conflicts","title":"NM_007294.3(BRCA1):c.4065_4068del (p.Asn1355fs) AND Hereditary breast and ovarian cancer syndrome","interpretation":"Pathogenic","trait_set_id":"7920","date_last_evaluated":"2019-01-09","version":"14","variation_archive_id":"VCV000017674","submission_count":"6"}
{"id":"RCV000159924","variation_id":"17674","review_status":"criteria provided, multiple submitters, no conflicts","title":"NM_007294.3(BRCA1):c.4065_4068del (p.Asn1355fs) AND not provided","interpretation":"Pathogenic","trait_set_id":"9460","date_last_evaluated":"2018-12-19","version":"4","variation_archive_id":"VCV000017674","submission_count":"2"}
{"id":"RCV000238776","variation_id":"17674","review_status":"criteria provided, single submitter","title":"NM_007294.3(BRCA1):c.4065_4068del (p.Asn1355fs) AND not specified","interpretation":"Pathogenic","trait_set_id":"9590","date_last_evaluated":"2016-07-01","version":"1","variation_archive_id":"VCV000017674","submission_count":"1"}
{"id":"RCV000131887","variation_id":"17674","review_status":"criteria provided, multiple submitters, no conflicts","title":"NM_007294.3(BRCA1):c.4065_4068del (p.Asn1355fs) AND Hereditary cancer-predisposing syndrome","interpretation":"Pathogenic","trait_set_id":"13598","date_last_evaluated":"2018-03-15","version":"6","variation_archive_id":"VCV000017674","submission_count":"2"}
{"id":"RCV000735453","variation_id":"17674","review_status":"no assertion criteria provided","title":"NM_007294.3(BRCA1):c.4065_4068del (p.Asn1355fs) AND Breast and/or ovarian cancer","interpretation":"Pathogenic","trait_set_id":"20192","date_last_evaluated":"2010-07-08","version":"1","variation_archive_id":"VCV000017674","submission_count":"1"}
